Notably, KCTD11 downregulation is associated with Gli1 and Patch1 overexpression, demonstrating that KCTD11 tumor suppressor gene acts as an inhibitor of Hedgehog signaling not only in medulloblastoma [20] but also in prostate cancer. This evidence concerns the gene KCTD11 and prostate cancer.